Lipohypertrophy: prevalence, clinical consequence, and pathogenesis

Chin Med J (Engl). 2020 Aug 17;134(1):47-49. doi: 10.1097/CM9.0000000000000970.
No abstract available

MeSH terms

  • Diabetes Mellitus, Type 1*
  • Humans
  • Insulin
  • Lipodystrophy* / chemically induced
  • Lipodystrophy* / epidemiology
  • Prevalence

Substances

  • Insulin